Wearable Mesh Nebulizer Portable Digital Handheld Nebulizer Machine Mesh Atomizer for Kids Adults

Description

Shenzhen Fitconn Technology Co.,ltd was founded in 2012 . It is a comprehensive enterprise dedicated to the research and development, manufacturing, sales and after-sales service of household medical products. The products cover nebulizer (compressor nebulizer, DC Compressor nebulizer and Mesh nebulizer), anti-decubitus air mattress, oximeters, fetal doppler, blood pressure monitors, etc. The business covers more than 150 countries around the world, with an average annual service of more than 2,000,000 family. Fitconn adheres to the concept of create health by heart, and is committed to improving the diversification of atomization methods, let’s households medical products and modern medical technology can benefit thousands of families around the world, with respect, tolerance, integrity, efficiency, innovation and persistence as core values, Integrate superior resources, take innovation as the source of development, and take science and technology as the foundation of success, and strive to provide each consumer with more professional, advanced and safer medical products. Fitconn has the class II medical device production qualification and over 50 patents , the company has passed the 13485 quality system certification, and some products have passed the EU CE and FDA certification

                

FITCONN MY-137B Wearable Mesh Nebulizer — Hands-Free Therapy That Ends the Ten-Minute Standoff

Nebulizer therapy carries a hidden compliance requirement that few product listings acknowledge: it demands that the patient sit still. A treatment session runs ten minutes, sometimes twenty, and for the entire duration the patient must hold the device, keep the mouthpiece seated, and refrain from the ordinary motions of living. Adults tolerate this. Children do not — and parents who have tried to hold a mask on a squirming toddler while the compressor hums on the table know that the tenth minute is usually when cooperation ends. The FITCONN MY-137B wearable mesh nebulizer removes the requirement rather than trying to enforce it. Manufactured by Shenzhen Fitconn Technology Co., Ltd. — 21 years in medical device production, a 4.9 out of 5 store rating, a 23% buyer reorder rate, and the number one factory ranking for household medical devices on the platform — this rechargeable ultrasonic device is worn on the body and delivers aerosol while the patient keeps moving: eating breakfast, reading, sleeping, or being carried.

Wear It, Pack It, Breathe Anywhere

The wearable configuration is the product's central architectural decision. Because the device travels on the patient rather than resting on a table, the therapy no longer requires a dedicated session in a seated position. A child can wear the nebulizer while playing; a working adult can wear it while at a desk; an elderly patient with limited mobility can wear it in bed without repositioning. The 10-milliliter medicine cup carries a full treatment volume, so a single fill covers the session while the patient remains otherwise unconstrained.

For pediatric use, this is the difference between a treatment that gets completed and one that gets abandoned. A device the child is wearing, rather than one being administered to them, shifts the psychological dynamic from confrontation to passive acceptance — the same principle that makes wearable medical devices more consistently used than their tethered equivalents. For families managing a chronic respiratory condition with daily therapy, consistent completion is the variable that determines clinical outcome.

Three Operating Modes for Dose-Time Control

The MY-137B offers three automatic shut-off modes at 5, 10, and 20 minutes, letting the caregiver match session length to the prescribed treatment. A five-minute mode handles a light maintenance dose or a young child's short session; ten minutes covers standard regimens; twenty minutes serves treatments requiring extended aerosol delivery. Because the shut-off is automatic and device-enforced, the caregiver does not need to watch a clock while supervising a child — a practical advantage in a household where treatments happen at bedtime, before school, or during an illness episode.

Operation is deliberately simplified, with a straightforward sequence that a caregiver can execute one-handed: fill the cup, seat the assembly, select the mode, and let the device run.

Quiet Enough to Disappear: ≤45 dB(A)

Working noise measures at or below 45 decibels — a figure that deserves context, because decibels are logarithmic, not linear. A reduction from 65 dB (typical for a compressor nebulizer) to 45 dB is not a 30% improvement; it represents a hundredfold reduction in sound energy, moving the device from the loudest object in the room to roughly the level of a quiet library. In practice this means a treatment can run in a shared bedroom without waking a sibling, in a classroom without drawing attention, or beside a sleeping spouse. Quiet operation also removes the startle response that makes young children resist treatment before it begins.

Mesh Engineering and the Cleaning Question

The core atomization technology is a vibrating mesh operating at approximately 110 kHz with a power consumption of roughly 1.5 watts, drawing on a built-in rechargeable battery. The nebulization rate is 0.25 milliliters per minute, producing particles with a mass median aerodynamic diameter below 5 micrometers — the size band associated with deposition in the lower airways, where inhaled medication needs to reach to be effective. Medicine temperature is held at or below 40°C, protecting heat-sensitive formulations during atomization, and the 10-milliliter capacity accommodates full adult doses as well as smaller pediatric volumes.

The device includes an automatic cleaning function, addressing the failure mode that shortens mesh nebulizer service life: dried medication residue narrowing the micro-perforated plate between treatments. The self-cleaning cycle flushes the spray path without disassembly, keeping the mesh within specification rather than letting it drift as residue accumulates. The unit is registered as a Class II medical instrument and constructed under safety standard GB2626-2006.

Certification, Volume Economics, and OEM Support

The MY-137B carries an EU Medical Device Regulation certificate issued by SGS under certificate number FI26/1008022, valid from 17 April 2025 through 16 April 2031, and the certificate explicitly covers mesh nebulizers — a detail that matters to importers who need the specific product category to appear on the documentation rather than a generic device class. Class II registration and CE certification complete the compliance picture, and the one-year warranty is supported by online technical support.

Customized logo, packaging, and graphic design are available for private-label programs, backed by a 9,500-square-meter facility, a workforce of over 100 including more than 30 quality-control staff, and a regular exhibition presence at Medica Germany, FIME USA, Arab Health Dubai, and CMEF China.

For pharmacies, pediatric distributors, and home healthcare retailers sourcing a wearable hands-free mesh nebulizer with three timed operating modes, 45-decibel operation, and lower-airway particle sizing for children and adults, the MY-137B answers the compliance problem that limits nebulizer therapy everywhere — not by asking the patient to be still, but by letting the treatment move with them.